Acesso livre
Acesso livre

Infectologia

Agência da União Europeia afirma que o foco deve ser sobre a oferta de vacinação inicial para todos, e não sobre as doses de reforço.

3 Set, 2021 | 12:50h

EU agency says to focus on vaccines first not booster shots – Associated Press

Ver também: European officials say COVID-19 booster isn’t urgent – CIDRAP

Opinião | “Os problemas em indicar o uso de máscaras por jovens estudantes são reais.”

3 Set, 2021 | 12:48h

The Downsides of Masking Young Students Are Real – The Atlantic

 

Comentário com réplica no Twitter (fio – clique para saber mais)

 

OMS afirma que está monitorando uma nova variante da Covid, chamada “mu”.

3 Set, 2021 | 12:45h

WHO says it is monitoring a new Covid variant called ‘mu’ – CNBC

Ver também:

What’s the Mu variant? And will we keep seeing more concerning variants? – The Conversation

WHO monitoring new coronavirus variant named ‘Mu’ – France 24

New ‘mu’ coronavirus variant could escape vaccine-induced immunity, WHO says – LiveScience

WHO monitoring new coronavirus variant named Mu – The Guardian

Reimaginando a construção e a renovação das unidades de cuidado em saúde após uma pandemia.

3 Set, 2021 | 12:44h

Reimagining Construction and Renovation of Health Care Facilities During Emergence from a Pandemic – Infectious Disease Clinics of North America

Estudo randomizado | Baricitinibe reduziu a mortalidade em adultos hospitalizados com COVID-19.

3 Set, 2021 | 11:22h

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial – The Lancet Respiratory Medicine

Comentários:

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial – The Lancet Respiratory Medicine

Rheumatoid Arthritis Drug Combined with Standard of Care May Help Reduce Mortality for Hospitalized COVID-19 Patients – Vanderbilt University Medical Center

 

Comentários no Twitter

(thread – click for more)

 

“Long COVID”: saúde física e mental de crianças e jovens não hospitalizados depois da infecção por SARS-CoV-2 – 1 em cada 7 crianças pode ainda ter sintomas 15 semanas depois da infecção.

3 Set, 2021 | 11:21h

Long COVID – the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study.

Comentários:

Long Covid in children ‘nowhere near scale feared’ – BBC

Long covid: One in seven children may still have symptoms 15 weeks after infection, data show – The BMJ

Conteúdos relacionados:

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.

 

Comentário no Twitter (fio – clique para saber mais)

 

Diretriz científica | Covid-19 e insuficiência cardíaca.

3 Set, 2021 | 11:19h

Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America – Journal of Cardiac Failure

 

Comentário no Twitter

 

Revisão | COVID-19 e doenças inflamatórias imunomediadas: efeitos da doença e do tratamento sobre os desfechos de COVID-19 e as respostas vacinais.

3 Set, 2021 | 11:17h

COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses – The Lancet Rheumatology

 

Comentário no Twitter

 

Outro estudo mostra redução da imunidade conferida pela vacina de mRNA da Pfizer ao longo do tempo.

3 Set, 2021 | 11:16h

Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar – medRxiv

Conteúdos relacionados:

[Press release – not published yet] Study shows vaccine protection wanes over time, but vaccines still offer good protection against severe disease.

Studies: COVID vaccine protection waning against infection but not hospitalization.

Pfizer says it’s time for a Covid booster; FDA and CDC say not so fast.

 

Comentário no Twitter (fio – clique para saber mais)

 

Recomendações para ventilação de espaços fechados para reduzir a transmissão de COVID-19.

3 Set, 2021 | 11:14h

Recommendations for ventilation of indoor spaces to reduce COVID-19 transmission – Journal of the Formosan Medical Association

Conteúdos relacionados:

We studied how to reduce airborne COVID spread in hospitals. Here’s what we learnt.

Report: Improved ventilation essential to safe use of buildings and public spaces, say leading engineers.

WHO: Roadmap to improve and ensure good indoor ventilation in the context of COVID-19

CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk

Guidance: Using Ventilation and filtration to reduce aerosol transmission of COVID-19 in long-term care homes

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.